Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Realfiction Holding AB announces its Q1 Interim Report for January – March 2022

Realfiction Holding AB (“Realfiction” or the “Company”) announces that the Q1 Interim Report for January – March 2022 is now available. The full report is attached as a separate document and can also be downloaded from the Company’s website (www.realfiction.com). A printed copy can be ordered via investor@realfiction.com. Below is a brief summary of the Q1 Interim Report.Important key figures:• 91% increase in total revenue Q1, 2022 compared to Q1, 2021• 139% increase in gross profit in Q1, 2022 compared to Q1, 2021• 24.9% increase (12.9 points) in gross profit margin in Q1, 2022

Ponsse’s new products for responsible forestry

Ponsse launches excellent new products to improve productivity in sustainable harvesting. The new solutions have been developed together with customers, listening to their needs. The PONSSE Scorpion Giant harvester and the PONSSE Mammoth forwarder respond to the highest requirements of modern forestry both in terms of ergonomics and productivity.   “These new products strengthen our position as one of the world’s leading suppliers of responsible harvesting solutions. The development of both new forest machines started from improved ergonomics, safety and usability, as well as better

Targovax announces publication of the two abstracts accepted for poster presentation at ASCO 2022

· The first poster summarizes the complete efficacy and immunological study data for the Targovax-sponsored mesothelioma trial, showing strong 30-month survival rate of 34.3% in the ONCOS-102-treated group vs. 18.2% in the control group · The second poster presents clinical data from the externally sponsored trial exploring intra-peritoneal (IP) delivery in colorectal or ovarian cancer with peritoneal metastasis, showing that ONCOS-102 generated immune responses and was safe to administer IP in combination with a PD-L1 checkpoint inhibitor Oslo, Norway, 27 May 2022 – Targovax ASA (OSE:

Cantargia presents clinical interim results at ASCO 2022 highlighting the potential of nadunolimab in combination with checkpoint inhibitor

Cantargia (Cantargia AB; Nasdaq Stockholm: CANTA) today reported new results from the phase Ib clinical trial CIRIFOUR in 15 solid tumor patients, no longer responding to PD-(L)1 inhibitor therapy, treated with nadunolimab (CAN04) as an add-on to Keytruda® (pembrolizumab). The results are positive, with favorable safety. Disease control for at least 30 weeks was also achieved by the combination in a patient subgroup, identified by lower levels of the biomarkers CRP and IL-6 and higher levels of immune cells in the tumor tissue at baseline. These results will be presented at the ASCO 2022

Cantargia presents new robust data at ASCO 2022 confirming promising effects of nadunolimab in treatment of pancreatic cancer

Cantargia (Cantargia AB; Nasdaq Stockholm: CANTA) today reported extended interim results in first-line pancreatic cancer (PDAC) patients treated with nadunolimab (CAN04) in combination with gemcitabine and nab-paclitaxel in the phase I/IIa CANFOUR trial. The efficacy was superior to historical data for chemotherapy only. In the 73 patients evaluable, median overall survival (OS) was 12.7 months with 1-year survival of 57% and median progression-free survival (iPFS) of 7.2 months. The safety profile was acceptable and in line with the earlier data set. These data strengthen previous positive

Cantargia: ASCO 2022 presentation strengthens positive phase IIa interim results for nadunolimab in NSCLC

Cantargia (Cantargia AB; Nasdaq Stockholm: CANTA) today reported updated interim results for non-small cell lung cancer (NSCLC) patients treated with nadunolimab (CAN04) in combination with gemcitabine and cisplatin, showing efficacy well above historical controls. With 30 patients evaluable, overall response rate (ORR) was 53%, disease control rate 83%, median progression-free survival (PFS) 6.8 months and median overall survival (OS) 13.7 months. The strongest efficacy benefits were seen in patients with non-squamous NSCLC, particularly those treated previously with a checkpoint inhibitor.

Investor Report

Regulatory Announcement Royal Bank of CanadaMay 26, 2022 RBC Covered Bond Programme Monthly Investor Report The RBC Covered Bond Programme Monthly Investor Report has been submitted to the National Storage Mechanism and will shortly be available for inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism To view the full document, please paste the following URL into the address bar of your browser. RBC Covered Bond Programme Monthly Investor Report dated April 29, 2022 http://www.rns-pdf.londonstockexchange.com/rns/9944M_1-2022-5-26.pdf A copy of the RBC

2nd Quarter Results

Regulatory Announcement Royal Bank of Canada May 26, 2022 Second Quarter 2022 Report to Shareholders The Second Quarter 2022 Report to Shareholders has been submitted to the National Storage Mechanism and will shortly be available for inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism To view the full document, please paste the following URL into the address bar of your browser. Second Quarter 2022 Report to Shareholders dated May 26, 2022 http://www.rns-pdf.londonstockexchange.com/rns/  A

2nd Quarter Results

Regulatory Announcement Second Quarter 2022 Earnings Release The Second Quarter 2022 Earnings Release has been submitted to the National Storage Mechanism and will shortly be available for inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism To view the full document, please paste the following URL into the address bar of your browser. Second Quarter 2022 Earnings Release dated May 26, 2022 http://www.rns-pdf.londonstockexchange.com/rns/9822M_1-2022-5-26.pdf A copy of the Second Quarter 2022 Earnings Release may also be viewed at www.rbc.com. For

Enauta’s FPSO Atlanta to be Operated to ABS Class

ABS Maintains FPSO Class Leadership in Brazil(DUBAI) The FPSO Atlanta, contracted by Enauta to Yinson for conversion to service the Atlanta Field offshore Brazil, will be operated under ABS Class. The Atlanta, which is being converted in Dubai Drydocks World, including structural upgrades, refurbishment and enhancement of equipment, will have a production capacity of 50,000 BOPD, 12.4 MMscfd gas and a storage capacity of 1,800,000 bbl. Operated by Enauta, the Atlanta Field is located in the Santos Basin, block BS-4, at 1,500 m water depth with estimated reserves of 106 MMbbl. Formerly

Realheart and KTH Receive SEK 4 Million Grant from Vinnova

Press release 26 May, 2022 Realheart and KTH have received a grant of SEK 4 million from Vinnova to jointly develop a Swedish hybrid simulator that will enable advanced testing of algorithms that control Realheart's artificial heart, but also will contribute to increasing Sweden's overall competitiveness in cardiovascular device innovation.A hybrid simulator consists of digital model of the human heart, lungs, and blood vessels, to which an artificial heart, for example, can be physically connected to study how the device interacts with the body. Similar methodology was used in the

Scandinavian ChemoTech’s TSE technology gives hope to horses suffering from sarcoids

Today the ESVONC congress in Syracuse, Italy, opens. In a poster, presented at the congress, the Tumour Specific Electroporation - TSE™ treatment of a horse is outlined and described as showing outstanding results.The author of this poster is DVM (Doctor in Veterinary Medicine) Majbritt M E Larsen, Specialist in small animal internal medicine and head of Oncology at Evidensia Specialistdjursjukhuset Helsingborg. The title of the poster is: “Treatment of equine sarcoids using intratumoral Bleomycin in combination with Tumour Specific Electroporation - TSE™” and describes the outstanding

Mental Health Awareness Month: How 9-to-5 Workers Can Improve Their Mental Health

Kasparas Aleknavičius, MD, Head of Medical Affairs at digital health and wellness accelerator Kilo Health, together with his team, has been researching the topic of mental health and sedentary lifestyle correlation. They seek to educate 9-to-5 workers to pursue a physically and mentally healthy life even if the circumstances can be aggravating.Over 80% of all US jobs are predominantly sedentary, and 8.4% of all US adults have faced a major depressive episode at least once in their lives. Various studies outline the correlations between lack of physical activity and emotional well-being. The

SAGA-PROPOSAL FROM THE NOMINATION COMMITTEE OF SAGA PURE ASA FOR THE ANNUAL GENERAL MEETING 30 MAY 2022

Reference is made to the stock exchange notice from Saga Pure ASA dated 9 May 2022, where the Company called for the Annual General Meeting for Saga Pure ASA to be held on 30 May 2022. Enclosed is the Recommendation from the Nomination Committee of Saga Pure ASA for the annual general meeting. For additional information, please contact: Espen Lundaas, CFO, +47 92 43 14 17 About Saga Pure ASA | www.sagapure.com Saga Pure ASA is an investment company focusing on opportunities within renewable energy, hydrogen, circular economy and CO2-reduction.

Time Series: unique feature for market analysis and data-based investments

Leading B2B provider of structured web data DomainCrawler announced the release of a new feature for its Domain Research platform – Time Series. This functionality will allow users to track the use of website technologies over a certain time range, gaining insights regarding the popularity of a certain application on the Internet.  DomainCrawler specializes in collecting and structuring raw web data. The company possesses a database of over 1.4 billion domain names

Sinch resolves on an in-kind issue of shares to the sellers of Pathwire

Stockholm, Sweden – 26 May 2022 – Sinch AB (publ) (the “Company” or “Sinch”), a global leader in cloud communications for mobile customer engagement, today announces that the board of directors, in accordance with what was communicated on 7 December 2021, has resolved on an in-kind share issue of 25.5 million shares to the sellers of Pathwire. On 30 September 2021, Sinch disclosed that it had entered into an agreement to acquire Pathwire and the acquisition was completed on 7 December 2021. In addition to the cash consideration, Sinch shall issue an aggregate of 51 million shares in the

Ingka Group approaching 500 companies to accelerate labour integration of refugees

Ingka Group announced today that it will approach 500 businesses with the aim to inspire the private sector to accelerate the labor integration of refugees. Speaking at the World Economic Forum in Davos, Ingka Group CEO Jesper Brodin said the company was also sharing their lessons learned in a toolkit to support and inspire more businesses to open pathways to decent work.“The human tragedy in Ukraine has put a spotlight on a global refugee crisis that has been building for years,” Brodin said. “While we know that short-term emergency relief is important, and we’re doing what we can, our

Read original

Capital increase in TORM due to exercise of Restricted Share Units as part of TORM’s incentive program

TORM plc (“TORM”) increases its share capital by 102,214 A-shares (corresponding to a nominal value of USD 1,022.14) as a result of the exercise of a corresponding number of Restricted Share Units.   The capital increase is carried out without any pre-emption rights for existing shareholders or others. All 102,214 new shares are subscribed for in cash. 74,436 of the new shares have been subscribed for at DKK 64.3 per A-share and the remaining 27,778 new shares have been subscribed for at DKK 53.5 per A-share. All with a nominal value of USD 0.01 each.   The new shares are

IFS Named A Leader in IDC MarketScape for Worldwide SaaS and Cloud-Enabled Manufacturing ERP in 2022

London, UK, May 26 2022 – IFS , the global cloud enterprise software company, today announced that it is positioned in the Leaders category in IDC MarketScape: Worldwide SaaS and Cloud-Enabled Manufacturing ERP Applications 2022 Vendor Assessment (doc #US49047922, May 2022) . The company attributes its continued growth and success to its deep industry expertise, innovative and flexible IFS Cloud solution, and service management expertise.The IDC MarketScape study provides an

Etrion Releases First Quarter 2022 Results.

May 26, 2022, Geneva, Switzerland – Etrion Corporation (“Etrion” or the “Company”, and, together with its subsidiaries, the “Group”) released today its condensed consolidated interim financial statements and related management’s discussion and analysis (“MD&A”) for the three months ended March 31, 2022. Q1-2022 HIGHLIGHTS · Etrion closed the first quarter of2022 with an unrestricted cash balance of US$18.1 million and a positive working capital of US$17.1 million. · The Company sold all the solar assets in 2021 and is not developing any new project in the first quarter 2022.

Pexip Holding ASA – Grant of Share Options to Senior Executives and Employee Share Options Exercise

The Board of Directors (“The Board”) of Pexip Holding ASA (“Pexip” or “The Company”) has on May 25, 2022 granted a total of 1,150,000 share options, equal to 1.1% of total shares issued in the Company, to members of the Company’s Senior Leadership Team. The exercise price is NOK 17.28 per share, which is equal to the volume-weighted average traded on Oslo Børs in the past seven days before the award, and the options are exercisable after December 31, 2024.  All options expire on December 31, 2026 and are conditional upon employment at time of exercise and the Company’s performance. 1/3 of

OPITO and NOWI announce partnership to support skills and safety in the US offshore wind sector

OPITO, the leading global safety and skills organisation for the energy industry, and the National Offshore Wind Institute (NOWI), based at Bristol Community College in Massachusetts, have today (Thursday 28[th]  April) signed a Memorandum of Understanding (MoU) which will support thousands of new jobs in the growing US offshore wind energy sector.Under the terms of the MoU, OPITO will work with NOWI to optimise workforce development and provide skills and safety training for the emerging New Bedford Port cluster in South Massachusetts and its pipeline of offshore wind projects. The U.S

Africa Oil Announces the Receipt of Prime Dividend

VANCOUVER, BC, May 25, 2022 /CNW/ - (AOI–TSX, AOI–Nasdaq-Stockholm) – Africa Oil Corp. (“AOI”, “Africa Oil” or “the Company”) is pleased to announce that it has received a dividend from Prime Oil and Gas Cooperatief UA (“Prime”). The Company has a 50% shareholding in Prime. Prime has distributed a $50.0 million dividend with a net payment to Africa Oil of $25.0 million related to its shareholding. This is the second Prime dividend distributed this year with Africa Oil having received an aggregate amount of $125.0 million. Since acquiring its 50% interest in Prime for a cash

ShaMaran Announces Successful Rights Offering Details

VANCOUVER, BC, May 25, 2022 /CNW/ - ShaMaran Petroleum Corp. (“ShaMaran” or the “Company”) (SNM: TSX-V and Nasdaq First North Growth Market (Sweden)) is pleased to announce further details following the Company’s news release of May 20, 2022 with respect to the Company’s rights offering (the ”Rights Offering”) that was oversubscribed by the Company’s shareholders and no call on the standby commitment of Nemesia S.à.r.l.1 was required.  ShaMaran has issued 558,242,414 common shares of the Company (the "Common Shares") at the price of CAD $0.06825 (SEK 0.52) per Common Share being the maximum

There are no items matching the current filter
There are no more items matching the current filter
Back to top